SCHEMBL30906420

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC

nearest known ligand 0.64

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	3/20	0.64

▸	NPY4R	P50391	3/20	0.64

▸	NPY5R	Q15761	3/20	0.64

▸	NPY1R	P25929	2/20	0.64

▸	CXCR4	P61073	3/20	0.62

▸	GLP1R	P43220	7/20	0.60

▸	CCKBR	P32239	2/20	0.60

▸	CALCR	P30988	4/20	0.59

▸	NMBR	P28336	1/20	0.57

▸	GRPR	P30550	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906535	1.00	NPY2R (0.64)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30906509	0.96	NPY2R (0.62)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL31000928	0.92	NPY2R (0.74)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL29479816	0.92	NPY2R (0.68)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL31000947	0.92	NPY2R (0.61)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30906533	0.92	GLP1R (0.62)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30277947	0.90	GLP1R (0.65)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30906404	0.89	NPY2R (0.65)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL31000923	0.89	GLP1R (0.68)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30567740	0.89	GLP1R (0.70)	NPY2RNPY4RNPY5RNPY1RCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed